Sleep Apnea and Weight Gain: Understanding the Connection
Key Takeaways
- Sleep apnea and weight gain share a two-way relationship. Obstructive sleep apnea (OSA) can lead to obesity, while obesity is a risk factor for developing OSA.
- OSA causes sleep disruptions that can impact hunger hormones, blood sugar regulation, and energy levels, all of which can contribute to weight gain.
- Carrying extra weight can affect the tissues of the mouth and throat, leading to the airway collapse that pauses breathing at night.
- An expanding landscape of treatment options allow for more personalized and effective OSA treatment.
- Unrecognized and untreated OSA is dangerous for your long-term health. Many people are good candidates for an at-home sleep study to evaluate for OSA.
If you know or suspect you have sleep apnea, you might also be concerned about recent weight gain. It’s true that sleep apnea and weight gain are related, and one condition can influence the other. Learning about their connection can help you get back in control of your health.
Gaining weight is frustrating, especially if you don’t know where the extra pounds are coming from. It might seem as if your diet, exercise, and sleep haven't changed. You’re not doing anything differently — but your body looks different. There may be something going on beneath the surface that you’re not aware of, like obstructive sleep apnea, or OSA.
OSA occurs when your upper airway becomes blocked during sleep, which causes brief pauses in your breathing throughout the night, according to the National Heart, Lung, and Blood Institute. Often associated with snoring or gasping during sleep, OSA can drive metabolic, hormonal, and physical changes that contribute to weight again. At the same time, excess weight can cause physical changes to your airway that increase your risk for developing OSA.
OSA can affect people at any weight, but those with obesity have four times higher odds of having OSA compared to people who are normal weight or underweight, according to research in eClinicalMedicine. However, it’s not fair to say that sleep apnea causes weight gain. That’s because weight is not the only risk factor, and not everyone with OSA has obesity. Learn more about this two-way connection, treatments for OSA, and how you can be screened for this sleep-related breathing disorder.
What is the connection between sleep apnea and weight gain?
There is a two-way relationship between OSA and obesity, says Ivania Rizo, MD, DABOM, spokesperson for The Obesity Society. “Each condition can make the other worse,” she says.
Excess weight can narrow breathing passages so they’re more likely to collapse during sleep, which causes microawakenings throughout the night. When it comes to obesity, there are several ways sleep apnea can contribute. “Untreated sleep apnea disrupts normal sleep and causes changes in hormones, metabolism, and energy levels that promote obesity,” says Rizo. This creates a cycle where obesity increases the risk of sleep apnea, and sleep apnea promotes weight gain and makes weight loss more difficult, she adds.
Still, the relationship between sleep apnea and obesity isn’t cut-and-dry. Not everyone with obesity has sleep apnea, and people of lower body weight can also develop sleep apnea due to factors like genetics, anatomy, and age, says Rizo.
How does sleep apnea affect weight?
OSA and weight gain are intrinsically linked. OSA causes several hormonal and metabolic changes that make it easier to gain weight or more challenging to lose it, says Rizo. Here’s a look at the biological processes that make these two conditions intertwine:
Sleep apnea and hunger hormones
Interrupted sleep from OSA disrupts hunger hormones, says Rizo. This means that sleep apnea and metabolism are deeply connected, and fluctuating weight is often a byproduct of that relationship.
Most notably, OSA is associated with high levels of the appetite-stimulating hormone ghrelin, according to research in Sleep Breathing Physiology. Normally, ghrelin levels rise to signal hunger and fall after eating. But with sleep apnea, it's not always so cut-and-dry: ghrelin can become dysregulated due to many factors besides interrupted sleep, such as disease severity and body weight. People with obesity often have lower fasting ghrelin levels and smaller-than-average drops in this hunger hormone after a meal, which may contribute to increased food intake.
In addition, research indicates that, for people with sleep apnea, leptin levels decrease initially, which may promote overeating and weight gain and obesity in the disease’s early stages. Over time, weight gain during OSA promotes leptin resistance, which can further affect appetite and weight, per Biochemistry and Biophysics Reports.
Then, there’s adiponectin, another hormone made in and released by fat tissue. It has a role in metabolic function because it supports insulin sensitivity, helps prevent plaque buildup in arteries, and has antiinflammatory properties, notes research in Life. This research found that people with OSA had lower levels of adiponectin than people without OSA. Authors note that this may mean that adiponectin may play a role in how OSA develops and continues over time, and may offer insight into why people with OSA are more likely to develop cardiovascular and metabolic problems.
It’s important to note that more research is needed to fully understand the complex way OSA and hunger hormones are related. But, what is clear is that sleep apnea contributes to a dysregulation of important hunger hormones like ghrelin that directly impact your body's metabolism.
National Heart, Lung, and Blood Institute. (2022, March 24). Sleep apnea - what is sleep apnea? Www.Nhlbi.Nih.Gov. https://www.nhlbi.nih.gov/health/sleep-apnea
Esmaeili, N., Gell, L., Imler, T., Hajipour, M., Taranto-Montemurro, L., Messineo, L., Stone, K. L., Sands, S. A., Ayas, N., Yee, J., Cronin, J., Heinzer, R., Wellman, A., Redline, S., & Azarbarzin, A. (2025). The relationship between obesity and obstructive sleep apnea in four community-based cohorts: an individual participant data meta-analysis of 12,860 adults. eClinicalMedicine, 83, 103221. https://doi.org/10.1016/j.eclinm.2025.103221
Sleep Apnea - Symptoms | NHLBI, NIH. (2022, March 24). Www.Nhlbi.Nih.Gov. https://www.nhlbi.nih.gov/health/sleep-apnea/symptoms
Najafi, A., Mohammadi, I., Sadeghi, M., Brühl, A. B., Sadeghi-Bahmani, D., & Brand, S. (2022). Evaluation of Plasma/Serum Adiponectin (an Anti-Inflammatory Factor) Levels in Adult Patients with Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis. Life, 12(5), 738. https://doi.org/10.3390/life12050738
National Heart, Lung, and Blood Institute. (2022, March 24). Sleep Apnea - Causes and Risk Factors | NHLBI, NIH. Www.Nhlbi.Nih.Gov. https://www.nhlbi.nih.gov/health/sleep-apnea/causes
Patil, S. P., Billings, M. E., Ghada Bourjeily, Collop, N. A., Gottlieb, D. J., Johnson, K. G., R. John Kimoff, & Pack, A. I. (2024). Long-term health outcomes for patients with obstructive sleep apnea: placing the Agency for Healthcare Research and Quality report in context—a multi-society commentary. Journal of Clinical Sleep Medicine, 20(1), 135–149. https://doi.org/10.5664/jcsm.10832
Tenda, E. D, Henrina, J., Cha, J. H., Triono, M. R., Putri, E. A., Aristy, D. J., & Tahapary, D. L. (2024). Obstructive sleep apnea: Overlooked comorbidity in patients with diabetes. World Journal of Diabetes, 15(7), 1448–1460. https://doi.org/10.4239/wjd.v15.i7.1448
Nicola Andrea Marchi, Gilles Allali, & Heinzer, R. (2024). Obstructive sleep apnea, cognitive impairment, and dementia: is sleep microstructure an important feature? Sleep. https://doi.org/10.1093/sleep/zsae161
Lee, S.-A., Im, K., Seo, J. Y., & Jung, M. (2022). Association between sleep apnea severity and symptoms of depression and anxiety among individuals with obstructive sleep apnea. Sleep Medicine. https://doi.org/10.1016/j.sleep.2022.09.023
Beatty, C. J., Landry, S. A., Mann, D. L., Joosten, S. A., Day, K., Bonham, M. P., O’Driscoll, D. M., Young, A., Ghazi, L., Murgia, C., Haines, T. P., Hamilton, G. S., & Edwards, B. A. (2026). Weight and sleep health in OSA: exploring their link. Frontiers in Sleep, 5. https://doi.org/10.3389/frsle.2026.1828583
National Heart, Lung, and Blood Institute. (2023, September 6). Sleep apnea - treatment. Www.Nhlbi.Nih.Gov. https://www.nhlbi.nih.gov/health/sleep-apnea/treatment
Slowik, J. M., & Collen, J. F. (2024). Obstructive sleep apnea. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459252/
FDA Approves First Medication for Obstructive Sleep Apnea. (2024, December 20). U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., Sands, S. A., Schwab, R. J., Dunn, J. P., Chakladar, S., Bunck, M. C., & Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine, 391(13). https://doi.org/10.1056/nejmoa2404881
D’Angelo, G. F., de Mello, A. A. F., Schorr, F., Gebrim, E., Fernandes, M., Lima, G. F., Grad, G. F., Yanagimori, M., Lorenzi-Filho, G., & Genta, P. R. (2023). Muscle and visceral fat infiltration: A potential mechanism to explain the worsening of obstructive sleep apnea with age. Sleep Medicine, 104, 42–48. https://doi.org/10.1016/j.sleep.2023.02.011
Anamei Silva-Reis, Brill, B., Alves, M., Renilson Moraes-Ferreira, Melamed, D., Helida Cristina Aquino-Santos, Frison, C. R., Albertini, R., Álvaro, R., Franco, V., Paixao-Santos, G., Oliveira, C. R., Abbasi, A., & Vieira, R. P. (2024). Association Between Visceral Fat and Lung Function Impairment in Overweight and Grade I Obese Women: A Cross-Sectional Study. Advances in Respiratory Medicine, 92(6), 548–558. https://doi.org/10.3390/arm92060048
Öztürk, Ö., Cebeci, D., Şahin, U., Tülüceoğlu, E. E., Calapoğlu, N. Ş., Gonca, T., & Calapoğlu, M. (2021). Circulating levels of ghrelin, galanin, and orexin-A orexigenic neuropeptides in obstructive sleep apnea syndrome. Sleep and Breathing, 26(3), 1209–1218. https://doi.org/10.1007/s11325-021-02514-w
Somers, K. R., Becari, C., Polonis, K., & Singh, P. (2025). Contrasting effects of acute versus chronic intermittent hypoxia on leptin secretion in differentiated human adipocytes – Implications for sleep apnea. Biochemistry and Biophysics Reports, 42, 102030. https://doi.org/10.1016/j.bbrep.2025.102030
Najafi, A., Mohammadi, I., Sadeghi, M., Brühl, A. B., Sadeghi-Bahmani, D., & Brand, S. (2022). Evaluation of Plasma/Serum Adiponectin (an Anti-Inflammatory Factor) Levels in Adult Patients with Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis. Life, 12(5), 738. https://doi.org/10.3390/life12050738
Sina, E. M., Shankar, S., Boon, M. S., & Huntley, C. T. (2025). Risk of Motor Vehicle Accidents in Obstructive Sleep Apnea: Comparative Analysis of CPAP Versus Surgery. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1131